KYOTO – Scientists from Kyoto University and Hyogo College of Medicine have found that cholesterol-fighting statins might help treat people with rare bone and cartilage diseases via iPS cells made from their own bodies.
Their research, published Wednesday in the online edition of the British science journal Nature, could help people with skeletal dysplasia, a group of rare diseases that affect skeletal growth through abnormalities in bone and cartilage, particularly types known as thanatophoric dysplasia and achondroplasia.
The study is remarkable in the sense that, by using iPS cells to re-create abnormal body cells, researchers have found the possibility that an existing drug could be used to treat another disease.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.